Sequoia Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Sequoia Financial Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-42,907	Closed	-$37K	–	392
2020 Q2	$37K	Sell	42,907 -25,814	-38%	-$22.7K	﹤0.01%	364
2020 Q1	$57K	Hold	68,721	–	–	﹤0.01%	355
2019 Q4	$61K	Buy	+68,721	New	+$57.2K	﹤0.01%	375
2019 Q3	–	Sell	-68,721	Closed	-$76K	–	374
2019 Q2	$76K	Sell	68,721 -14	-0%	-$16	0.01%	366
2019 Q1	$90K	Buy	68,735 +35	+0.1%	+$44	0.01%	359
2018 Q4	$63K	Sell	68,700 -14,110	-17%	-$21.6K	0.01%	287
2018 Q3	$170K	Buy	82,810 +33,775	+69%	+$70.9K	0.02%	303
2018 Q2	$88K	Sell	49,035 -6,953	-12%	-$14K	0.01%	298
2018 Q1	$132K	Hold	55,988	–	–	0.01%	294
2017 Q4	$105K	Hold	55,988	–	–	0.01%	296
2017 Q3	$139K	Hold	55,988	–	–	0.02%	275
2017 Q2	$154K	Hold	55,988	–	–	0.02%	270
2017 Q1	$169K	Hold	55,988	–	–	0.02%	271
2016 Q4	$177K	Hold	55,988	–	–	0.03%	259
2016 Q3	$191K	Hold	55,988	–	–	0.04%	229
2016 Q2	$128K	Sell	55,988 -641	-1%	-$1.57K	0.04%	239
2016 Q1	$142K	Buy	56,629 +997	+2%	+$2.23K	0.05%	187
2015 Q4	$184K	Hold	55,632	–	–	0.07%	165
2015 Q3	$135K	Buy	+55,632	New	+$144K	0.06%	166

Other funds holding LCTX

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sequoia Financial Advisors's LCTX Position: Q3 2020 in Review

Sequoia Financial Advisors sold out of Lineage Cell Therapeutics (LCTX) in Q3 2020, closing a stake of 42,907 shares — an estimated $37K sold.

Sequoia Financial Advisors first reported a position in LCTX in Q3 2015 and held it in 19 quarters. The position peaked at $191K in Q3 2016. 75 funds tracked by Wall St. Rank hold LCTX as of Q3 2020.

Sequoia Financial Advisors reported no remaining Lineage Cell Therapeutics position as of Q3 2020 after selling out during the quarter.
Sequoia Financial Advisors sold 42,907 Lineage Cell Therapeutics shares in Q3 2020, an estimated $37K.
Sequoia Financial Advisors first reported a position in Lineage Cell Therapeutics in Q3 2015 and held it in 19 quarters.
Sequoia Financial Advisors's Lineage Cell Therapeutics position peaked at $191K in Q3 2016.
75 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2020.

Based on Sequoia Financial Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.